18F-G168Ga-grazytracergranzyme Bmalignant tumorsSR-717-treated tumorsimmunotherapy
…d chelator and radiolabeled with Al 18F to generate radiotracer 18F-G1. Its imaging and pharmacokinetic properties were compared with …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,321–1,380 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
ascorbic acid3calcitriol3canakinumab3chenodeoxycholic acid3cisplatin-induced3condoms3contraceptive pill3cytarabine3dextran sodium sulfate3diamorphine3diazinon3direct oral anticoagulants3donepezil3drug3elranatamab3endothelin receptor antagonists3etoricoxib3famotidine3flunarizine3glucagon-like peptide-1 receptor agonist3glucose-lowering medications3illicit drugs3immunosuppressive agents3immunotherapies3intra-arterial verapamil3intrathecal opioids3intravenous acyclovir3intravenous fentanyl3intravenous ketamine3intravenous thrombolysis3isocyanates3long-acting nitrates3mRNA vaccines3medicine3neuromodulators3new drug3new drugs3nitroglycerin3opiates3oral doxycycline3pharmaceuticals3piperacillin–tazobactam3prescription medications3pulse oximetry3ramipril3reslizumab3sedatives3small molecules3taxane3tenofovir disoproxil3tepotinib3tetracyclines3thyroid-stimulating hormone3tissue plasminogen activator3topical antibiotics3tricyclic antidepressants3trimethoprim/sulfamethoxazole3trimethoprim–sulfamethoxazole3vitamin K antagonists3weight loss drugs3
Articles mentioning drugs
10,506 articles · page 100 of 876glucosamineAlbuminuriaUK Biobank
…of the vascular endothelium in a potential protective effect of glucosamine use on many health outcomes, whether this relationship is causa…
ErtapenemTazocinantibioticsMarie Curie Hospice
… who had received a course of SC antibiotics (Tazocin (86%) and Ertapenem (14%)) were included. Only 1 of 7 patients (14%) experienced lo…
originator adalimumabadalimumabNIUnon-infectious uveitisuveitis
…yes of 148 patients diagnosed with NIU were treated with either originator adalimumab (n=193, 74.23%) or a biosimilar (n=67, 25.77%). Median follow-u…
rVAR2AXVB5H4VAR2omabB-cell hematological malignancies
…rine model of hematologic malignancy, CAR-T cells utilizing the rVAR2 catenane (AXVB) as a targeting module exhibited superior antitu…
antibioticsself-limiting diseasesviral infections
…sed to treat viral infections, pain or allergies and that using antibiotics without consulting a medical professional is not safe. During p…
muscle relaxantGabapentinopioidgabapentinoidbenzodiazepineTBILBFtraumatic brain injury
…to 2022 (6.8% vs 19.3%; aRR 2.80 (95% CI 2.52 to 3.11)) whereas muscle relaxant use did not change (14.5% vs 13.5%; aRR 0.93 (95% CI 0.85 to 1.…
ILKN421Hpembrolizumabadvanced solid tumors1L NSCLC
…ed so far. In Part A, 9 patients in three dose cohorts received ILKN421H. All patients demonstrated high and prolonged plasma level of I…
HCB101HCB101-basedHCB101-201nab-paclitaxelramucirumabpaclitaxeltoripalimabgastric cancerhead and neck squamous cell carcinomatriple-negative breast cancer+1 more
… plus ramucirumab and paclitaxel); and b) first-line (1L) TNBC (HCB101 plus toripalimab and nab-paclitaxel). Primary endpoints were sa…
JL18008lymphocytopeniaPeking Union Medical College HospitalT cell-compromised infectious or malignant diseasesClinical Pharmacology Research CenterInstitutional Review Board
…he only grade 3 AE observed, in 1 subject receiving 70 μg/kg of JL18008. The dose range of 20 to 70 μg/kg is anticipated to be the effe…
AVO-100AAVB cell malignanciesRaji lymphomaB cell lymphomaFDA-approvedFDA
…-specific CAR-T cells, generated in vivo from human PBMCs using AVO-100, control Raji tumor growth (A), improve mouse survival (B) and …
Hhepanti-PD1melanomacolorectal cancer
…-PD1. Hhep was only present in tumors of mice treated with both Hhep and anti-PD1. Dual treatment resulted in a significant increase…